CoChat

Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis

Luzi, Livio, Barrett, Eugene J, Groop, Leif C, Ferrannini, Eleuterio, DeFronzo, Ralph A · 1988 · Diabetes
Cited by 122

The DOI matches its Crossref record.

Abstract

The effect of low-dose insulin treatment (5–10 U/h) on hepatic glucose production (HGP) and peripheral glucose disposal was determined in 5 insulindependent diabetes mellitus (IDDM) subjects who were admitted with diabetic ketoacidosis (DKA; plasma glucose 598 ± 50 mg/dl, blood pH 7.20 ± 0.06, plasma bicarbonate 12 ± 2 meq/L). Basal hepatic glucose production (4.3 ± 0.5 mg · kg1 min1) in the DKA patients was 1.5- to 2-fold greater (P < .01) than in controls (2.1 ± 0.1 mg · kg−1 · min−1) and nonketotic IDDM subjects (2.9 ± 0.3 mg · kg−1 · min−1), whereas tissue glucose disposal was significantly reduced (1.7 ± 0.1 vs. 2.1 ± 0.1 mg kg−1 min−1 P < .05). After the institution of insulin therapy (1 mU · kg−1 · min−1), the plasma glucose concentration fell at the rate of 60 ± 5 mg· dl−1 h−1 to reach a value of 220 ± 10 mg/dl, which was maintained constant for 2 h (insulinclamp technique). Blood pH (7.21 ± 0.06 to 7.35 ± 0.05) and plasma bicarbonate (12 ± 3 to 18 ± 2 meq\L) both increased during insulin therapy (P < .01). The decline in plasma glucose concentration during insulin therapy primarily resulted from a suppression of HGP (from 4.3 ± 0.5 to 1.7 ± 0.2 mg · kg−1 min−1 P < .01) and to a lesser extent from the stimulation of tissue glucose disposal (1.7 ± 0.2 to 2.6 ± 0.3 mg kg−1 min−1 P < .01). At this time, urine glucose excretion decreased from 2.6 ± 0.2 to 0.6 ± 0.1 mg kg−1 min−1. During the 2-h period of the insulin clamp (steady-state plasma glucose 220 ± 1 0 mg/dl, plasma free insulin 85 ± 5 (ill/ml), HGP in the DKA patients was further suppressed (1.70 ± 0.20 to 1.00 ± 0.20 mg · kg−1 min−11) but remained well above (P < .01) rates observed in control subjects (0.1 ± 0.02 mg · kg−1 · min−1) and nonketotic diabetic subjects (0.2 ± 0.1 mg · kg−1 · min−1). At the end of the 2-h insulin-clamp period, the rate of tissue glucose uptake (3.2 ± 0.3 mg kg−1 · min−1) had not increased significantly above the rate observed at the start of the clamp (2.6 ± 0.2 mg/kg). Urinary glucose losses during the insulin-clamp period averaged 0.10 ± 0.01 mg · kg−1 · min−1. In summary, in DKA, 1) hyperglycemia results from both a markedly increased rate of HGP and a modest decrease in tissue glucose uptake, 2) the ability of insulin to suppress HGP and to stimulate tissue glucose uptake is severely impaired, and 3) during the initial 6-h period of insulin therapy, urinary glucose losses (0.4 mg kg−1 min−1), stimulation of tissue glucose uptake (increment 1.5 mg kg−1 min−1), and suppression of HGP (decrement 3.3 mg · kg−1 · min−1) all contributed to the decline in plasma glucose. However, from the quantitative standpoint, inhibition of HGP is the most important determinant in the decline in plasma glucose concentration after institution of insulin therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.37.11.1470

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 122

Metadata

Authors
Luzi, L., Barrett, E. J., Groop, L. C., Ferrannini, E., & DeFronzo, R. A.
Venue
Diabetes
Published
1988-11-01
Volume
37
Issue
11
Pages
1470-1477
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2130213301
Cited by
122
References
0
FWCI
2.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis. https://app.cochat.ai/papers/10.2337/diab.37.11.1470
The paper
Luzi, L., Barrett, E. J., Groop, L. C., Ferrannini, E., & DeFronzo, R. A. (1988). Metabolic Effects of Low-Dose Insulin Therapy on Glucose Metabolism in Diabetic Ketoacidosis. Diabetes. https://doi.org/10.2337/diab.37.11.1470

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.